Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
NEGG Newegg Commerce Inc
PHX PHX Minerals Inc
IRT Independence Realty Trust Inc
RLAY Relay Therapeutics Inc
CVU CPI Aerostructures Inc
MA Mastercard Inc
WDBG Neuro-Hitech Inc
GLRY Inspire Faithward Mid Cap Momentum ETF
WCC Wesco International Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Closing Price
$0.83
Day's Change
-0.0566 (-6.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.907
Day's Low
0.83
Volume
(Light)
Volume:
4,584,488

10-day average volume:
9,975,315
4,584,488

DEADLINE ALERT for FIGS, FRSH, and EVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

10:25 am ET January 3, 2023 (Globe Newswire) Print
DEADLINE ALERT for FIGS, FRSH, and EVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersGlobeNewswireJanuary 03, 2023

LOS ANGELES , Jan. 03, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com.

FIGS, Inc. (NYSE: FIGS)

Class Period: May 27, 2021 - May 12, 2022

Lead Plaintiff Deadline: January 3, 2023

The complaint filed in this class action alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants: (1) inflated the Company's true ability to successfully secure repeat customers; (2) failed to disclose the Company's increasing dependence on air freight; (3) inflated the expected net revenues, gross margin, and adjusted EBITDA margin for 2022; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you are a FIGS shareholder who suffered a loss, click here to participate.

Freshworks Inc. (NASDAQ: FRSH)

Class Period: September 22, 2021 - November 1, 2022

Lead Plaintiff Deadline: January 3, 2023

The complaint filed in this class action alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Freshworks' net dollar retention rate had plateaued while its revenue growth rate and billings were decelerating, and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you are a Freshworks shareholder who suffered a loss, click here to participate.

Enviva Inc. (NYSE: EVA)

Class Period: February 21, 2019 - October 11, 2022

Lead Plaintiff Deadline: January 3, 2023

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Enviva had misrepresented the environmental sustainability of its wood pellet production and procurement; (2) Enviva had similarly overstated the true measure of cash flow generated by the Company's platform; (3) accordingly, Enviva had misrepresented its business model and the Company's ability to achieve the level of growth that Defendants had represented to investors; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you are an Enviva shareholder who suffered a loss, click here to participate.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

fcruz@frankcruzlaw.com

www.frankcruzlaw.com



Primary Logo

comtex tracking

COMTEX_421827348/2010/2023-01-03T10:25:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.